Acorah Software Products - Accounts Production 19.2.450 false true false true No description of principal activity 24 October 2024 31 October 2025 31 October 2025 16039345 Dr Lea Wenger Dr Kevin Chalut iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16039345 2024-10-23 16039345 2025-10-31 16039345 2024-10-24 2025-10-31 16039345 frs-core:CurrentFinancialInstruments 2025-10-31 16039345 frs-bus:PrivateLimitedCompanyLtd 2024-10-24 2025-10-31 16039345 frs-bus:FilletedAccounts 2024-10-24 2025-10-31 16039345 frs-bus:Micro-entities 2024-10-24 2025-10-31 16039345 frs-bus:AuditExempt-NoAccountantsReport 2024-10-24 2025-10-31 16039345 frs-bus:Director1 2024-10-24 2025-10-31 16039345 frs-bus:Director2 2024-10-24 2025-10-31
Registered number: 16039345
Cyclana Bio Ltd
Unaudited Financial Statements
For the Period 24 October 2024 to 31 October 2025
IP Tax Solutions Ltd
Statement of Financial Position
Registered number: 16039345
31 October 2025
£
Fixed assets 8,607
Current assets 4,958,651
Prepayments and accrued income 1,375
Creditors: Amounts Falling Due Within One Year (45,124 )
NET CURRENT ASSETS 4,914,902
TOTAL ASSETS LESS CURRENT LIABILITIES 4,923,509
Accruals and deferred income (36,000 )
NET ASSETS 4,887,509
CAPITAL AND RESERVES 4,887,509

Notes

1. General Information
Cyclana Bio Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16039345 . The registered office is Meditrina Building 260, Babraham Research Campus, Babraham, Cambridge, CB22 3AT.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Lea Wenger
Director
09/07/2026